Medical device licence · 104482 · Class 2
COMASP
Yes: licensed in Canada
Licence status Issued (active); first licensed March 24, 2020. It is in Health Canada’s list of active licences.
- Licence number
- 104482
- Licence holder
- Liofilchem S.R.L.Roseto Degli Abruzzi, TE, Italy
- Risk class
- Class II (low to moderate risk)
- Licence type
- Device Family
- First licensed
- March 24, 2020
- Devices covered
- 8
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- "COMASP CEFTOLOZANE-TAZOBACTAM / CEFTAZIDIME-AVIBACTAM CEFTAZIDIME-AVIBACTAM"
- COMASP CEFIDEROCOL
- COMASP CEFTOLOZANE-TAZOBACTAM
- COMASP COLISTIN
- COMASP COLISTIN / PIPERACILLIN TAZOBACTAM
- COMASP PIPERACILLIN*-TAZOBACTAM
- COMASP VANCOMYCIN
- COMASP VANCOMYCIN / TEICOPLANIN
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.